Treatment of acute subdural haematoma - Authors' reply
- PMID: 36402156
- DOI: 10.1016/S1474-4422(22)00433-1
Treatment of acute subdural haematoma - Authors' reply
Conflict of interest statement
AIRM declares consulting fees from PresSura Neuro, Integra Life Sciences, and NeuroTrauma Sciences. EWS reports personal fees from Springer during the conduct of the study. All other authors declare no competing interests. The authors’ work on this study is funded by the Hersenstichting Nederland (the Dutch Brain Foundation, grant number ps2014.06) for the Dutch Neurotraumatology Quality Registry19 and the EU seventh Framework Programme (grant 602150) for CENTER-TBI. Additional support for CENTER-TBI was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), from Integra LifeSciences Corporation (USA), and from NeuroTrauma Sciences (USA).
Comment on
-
Surgery versus conservative treatment for traumatic acute subdural haematoma: a prospective, multicentre, observational, comparative effectiveness study.Lancet Neurol. 2022 Jul;21(7):620-631. doi: 10.1016/S1474-4422(22)00166-1. Epub 2022 May 5. Lancet Neurol. 2022. PMID: 35526554
-
Treatment of acute subdural haematoma.Lancet Neurol. 2022 Dec;21(12):1080. doi: 10.1016/S1474-4422(22)00434-3. Lancet Neurol. 2022. PMID: 36402155 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
